Clinical Analysis of Tocolysis with Ritodrine Hydrochloride or Atosibanin Treatment of Threatened Preterm Labour

ZHANG Zhanwei,ZHANG Meng,LV Min

2023-01-01

Abstract:Objective:To assess the efficacy of two tocolytic agents, ritodrine hydrochloride and atosiban, for inhibiting preterm labour.Methods:The clinical data of 284 patients diagnosed with preterm labour, hospitalised and delivered in Women′s Hospital School of Medicine Zhejiang University from December 2018 to December 2020 were retrospectively reviewed.They were divided into three groups which are the intravenous ritodrine hydrochloride group, the atosiban group, and the alternative group according to the use of tocolysis.Screening for statistically significant outcome indicators by group comparison and controlling the confounding factors by Logistic regression, the maternal and neonatal outcomes were compared among three groups and quantitatively assessmented by corrected OR.Results:（1）Atosiban（OR 7.932,95%CI 1.722-36.526）group and alternative（OR 4.054,95%CI 1.649-9.965）group showed higher risks of giving birth before 28 weeks than ritodrine hydrochloride group（P＜0.01）.（2）Compared to ritodrine hydrochloride group, atosiban（HR 5.942,95%CI 1.736-20.335）group and alternative（HR 3.030,95%CI 1.565-5.865）group had less increase in the mean gestational age at delivery; the adverse drug reactions in atosiban group were less than those in ritodrine hydrochloride group and alternative group（P＜0.01）.（3）No apparent differences were showed between ritodrine hydrochloride and other two groups in live birth rate（P＞0.05）.（4）There were also no significant differences between ritodrine hydrochloride group and atosiban group in infant admission to neonatal intensive care unit（NICU）,neonatal respiratory distress syndrome（NRDS）,apnea, or need for mechanical ventilation.While there were higher event rates for these risks in alternative group compared with ritodrine hydrochloride group（P＜0.05）,OR=2.302（95%CI 1.149-4.612）,5.569（95%CI 2.380-13.033）,6.487（95%CI 2.564-16.409）,6.839（95%CI 2.896-16.152）.Conclusions:Monotherapy with ritodrine hydrochloride was more effective than monotherapy with atosiban and alternative therapy with these two medications for inhibiting preterm labour and prolonging the duration of pregnancy.However, atosiban had less adverse drug reactions compared with ritodrine hydrochloride.Suitable use of medications should be explored by further randomized controlled studies.